Adenocarcinoma of the prostate with atrophic features

Stephen J. Cina, Jonathan Ira Epstein

Research output: Contribution to journalArticle

Abstract

Adenocarcinomas of the prostate with attenuated cytoplasm (i.e., atrophic features) have not been studied formally and represent a diagnostic dilemma to the surgical pathologist. Forty-four cases of adenocarcinoma with atrophic features seen at the Johns Hopkins Medical Institutions were reviewed. Forty-two cases were seen on needle biopsy, and two were from transurethral resection specimens. Neoplastic atrophic glands were characterized by cells with a paucity of cytoplasm, such that the nuclei occupied almost the entire cell height. Atrophic cancers were defined as cancers with atrophic glands constituting ≤50% of the tumor. Only two of 44 patients whose prostatic adenocarcinoma showed atrophic features were on hormone therapy at the time of biopsy. Forty-one cases had an infiltrative pattern of growth. Thirty-nine cases were Gleason grade 3 + 3 = 6. Nuclear size was increased in 39 cases, and macronucleoli were noted in 21 cases. The most useful criteria to establish a diagnosis of adenocarcinoma were (1) an infiltrative pattern of growth, (2) the presence of macronucleoli, (3) increased nuclear size, and (4) the presence of adjacent, nonatrophic cancer.

Original languageEnglish (US)
Pages (from-to)289-295
Number of pages7
JournalAmerican Journal of Surgical Pathology
Volume21
Issue number3
DOIs
StatePublished - Mar 1997

Fingerprint

Prostate
Adenocarcinoma
Neoplasms
Cytoplasm
Needle Biopsy
Growth
Hormones
Biopsy
Therapeutics

Keywords

  • Atrophy
  • Prostate
  • Prostatic adenocarcinoma

ASJC Scopus subject areas

  • Anatomy
  • Pathology and Forensic Medicine

Cite this

Adenocarcinoma of the prostate with atrophic features. / Cina, Stephen J.; Epstein, Jonathan Ira.

In: American Journal of Surgical Pathology, Vol. 21, No. 3, 03.1997, p. 289-295.

Research output: Contribution to journalArticle

@article{89dc8d59115947d193e0f88c8821ce54,
title = "Adenocarcinoma of the prostate with atrophic features",
abstract = "Adenocarcinomas of the prostate with attenuated cytoplasm (i.e., atrophic features) have not been studied formally and represent a diagnostic dilemma to the surgical pathologist. Forty-four cases of adenocarcinoma with atrophic features seen at the Johns Hopkins Medical Institutions were reviewed. Forty-two cases were seen on needle biopsy, and two were from transurethral resection specimens. Neoplastic atrophic glands were characterized by cells with a paucity of cytoplasm, such that the nuclei occupied almost the entire cell height. Atrophic cancers were defined as cancers with atrophic glands constituting ≤50{\%} of the tumor. Only two of 44 patients whose prostatic adenocarcinoma showed atrophic features were on hormone therapy at the time of biopsy. Forty-one cases had an infiltrative pattern of growth. Thirty-nine cases were Gleason grade 3 + 3 = 6. Nuclear size was increased in 39 cases, and macronucleoli were noted in 21 cases. The most useful criteria to establish a diagnosis of adenocarcinoma were (1) an infiltrative pattern of growth, (2) the presence of macronucleoli, (3) increased nuclear size, and (4) the presence of adjacent, nonatrophic cancer.",
keywords = "Atrophy, Prostate, Prostatic adenocarcinoma",
author = "Cina, {Stephen J.} and Epstein, {Jonathan Ira}",
year = "1997",
month = "3",
doi = "10.1097/00000478-199703000-00004",
language = "English (US)",
volume = "21",
pages = "289--295",
journal = "American Journal of Surgical Pathology",
issn = "0147-5185",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Adenocarcinoma of the prostate with atrophic features

AU - Cina, Stephen J.

AU - Epstein, Jonathan Ira

PY - 1997/3

Y1 - 1997/3

N2 - Adenocarcinomas of the prostate with attenuated cytoplasm (i.e., atrophic features) have not been studied formally and represent a diagnostic dilemma to the surgical pathologist. Forty-four cases of adenocarcinoma with atrophic features seen at the Johns Hopkins Medical Institutions were reviewed. Forty-two cases were seen on needle biopsy, and two were from transurethral resection specimens. Neoplastic atrophic glands were characterized by cells with a paucity of cytoplasm, such that the nuclei occupied almost the entire cell height. Atrophic cancers were defined as cancers with atrophic glands constituting ≤50% of the tumor. Only two of 44 patients whose prostatic adenocarcinoma showed atrophic features were on hormone therapy at the time of biopsy. Forty-one cases had an infiltrative pattern of growth. Thirty-nine cases were Gleason grade 3 + 3 = 6. Nuclear size was increased in 39 cases, and macronucleoli were noted in 21 cases. The most useful criteria to establish a diagnosis of adenocarcinoma were (1) an infiltrative pattern of growth, (2) the presence of macronucleoli, (3) increased nuclear size, and (4) the presence of adjacent, nonatrophic cancer.

AB - Adenocarcinomas of the prostate with attenuated cytoplasm (i.e., atrophic features) have not been studied formally and represent a diagnostic dilemma to the surgical pathologist. Forty-four cases of adenocarcinoma with atrophic features seen at the Johns Hopkins Medical Institutions were reviewed. Forty-two cases were seen on needle biopsy, and two were from transurethral resection specimens. Neoplastic atrophic glands were characterized by cells with a paucity of cytoplasm, such that the nuclei occupied almost the entire cell height. Atrophic cancers were defined as cancers with atrophic glands constituting ≤50% of the tumor. Only two of 44 patients whose prostatic adenocarcinoma showed atrophic features were on hormone therapy at the time of biopsy. Forty-one cases had an infiltrative pattern of growth. Thirty-nine cases were Gleason grade 3 + 3 = 6. Nuclear size was increased in 39 cases, and macronucleoli were noted in 21 cases. The most useful criteria to establish a diagnosis of adenocarcinoma were (1) an infiltrative pattern of growth, (2) the presence of macronucleoli, (3) increased nuclear size, and (4) the presence of adjacent, nonatrophic cancer.

KW - Atrophy

KW - Prostate

KW - Prostatic adenocarcinoma

UR - http://www.scopus.com/inward/record.url?scp=0030892189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030892189&partnerID=8YFLogxK

U2 - 10.1097/00000478-199703000-00004

DO - 10.1097/00000478-199703000-00004

M3 - Article

VL - 21

SP - 289

EP - 295

JO - American Journal of Surgical Pathology

JF - American Journal of Surgical Pathology

SN - 0147-5185

IS - 3

ER -